Brinaldix

Brinaldix Medicine

Contraindications

Hypersensitivity (including to sulfonamides), hepatic or severe renal failure, Addison's disease, hypokalemia, hyponatremia, hypochloremia, uremia.

Incompatibilities

Increases the activity of antihypertensive drugs, increases the risk of intoxication with cardiac glycosides, reduces the effectiveness of hypoglycemic drugs.

Undesirable effects

From the side of water-electrolyte exchange: hyponatremia, hypokalemia, etc.

From the gastrointestinal tract: nausea, vomiting.

From the cardiovascular system: arrhythmias, orthostatic hypotension.

Other: muscle weakness, allergic reactions.

Therapeutic indications

Edema of various origins, arterial hypertension.

Pharmacotherapeutic group

  • Diuretics

Special precautions for storage

In a dry, dark place.

Keep out of reach of children.

The shelf life of the drug Rinaldis5 лет.

Do not use after the expiration date indicated on the package.

Nature and contents of container

1 tablet contains clopamide 20 mg, in vials of 20 pcs., in a box of 1 bottle.

Fertility, pregnancy and lactation

Perhaps with caution, for the period of reception, you should refuse to breastfeed.

Nosological classification (ICD-10)

  • I10 Essential (primary) hypertension
  • I15 Secondary hypertension
  • I50. 0 Congestive heart failure
  • K76. 6 Portal hypertension
  • N04 Nephrotic syndrome
  • R18 Ascites
  • R60 Edema, not classified elsewhere

Dosage (Posology) and method of administration

Inside, preferably in the morning. Edematous syndrome: in the initial dose of 20-40 mg per day, if necessary, the dose can be increased to 60-80 mg. The maintenance dose is 10 mg per day or 20 mg every other day.

Arterial hypertension: 5-10 mg, in case of resistance-up to 20 mg per day.

ATC - Anatomical and therapeutic chemical classification

C03BA03 Clopamide